SELLAS Life Sciences Group, Inc. (FRA:RXK3)
3.535
+0.030 (0.86%)
Last updated: Jan 20, 2026, 7:54 PM CET
246.57% (1Y)
| Market Cap | 540.34M +714.4% |
| Revenue (ttm) | n/a |
| Net Income | -22.11M |
| EPS | -0.24 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 450 |
| Average Volume | 1,677 |
| Open | 3.370 |
| Previous Close | 3.505 |
| Day's Range | 3.250 - 3.535 |
| 52-Week Range | 0.883 - 4.495 |
| Beta | n/a |
| RSI | 50.41 |
| Earnings Date | Mar 18, 2026 |